{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:47:43Z","timestamp":1759366063622,"version":"build-2065373602"},"reference-count":64,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.gastrohep.2022.02.004","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T11:30:19Z","timestamp":1646393419000},"page":"715-723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treatment of refractory ascites: Current strategies and new landscape of non-selective beta-blockers"],"prefix":"10.1016","volume":"45","author":[{"given":"David","family":"Vidal Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla Paola","family":"P\u00e9rez L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa\u00fal Andr\u00e9","family":"Vera Nungaray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Guillermo","family":"Moreno Madrigal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2022.02.004_bib0325","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D\u2019Amico","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0330","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1478-3231.2012.02830.x","article-title":"Prognostic indicators of survival in patients with compensated and decompensated cirrhosis","volume":"32","author":"Zipprich","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0335","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1478-3231.2010.02272.x","article-title":"Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis","volume":"30","author":"Salerno","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0340","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2214\/ajr.165.1.7785576","article-title":"The role of imaging in patients with ascites","volume":"165","author":"Thoeni","year":"1995","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0345","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010;53:397\u2013417.","DOI":"10.1016\/j.jhep.2010.05.004"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0350","doi-asserted-by":"crossref","first-page":"S288","DOI":"10.1097\/MCG.0b013e3181468b4c","article-title":"The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension","volume":"41","author":"Iwakiri","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0355","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mam.2007.09.006","article-title":"Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis","volume":"29","author":"Gatta","year":"2008","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0360","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2005.02.022","article-title":"Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats","volume":"43","author":"Fernandez","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0365","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jhep.2014.05.047","article-title":"Vascular pathobiology in chronic liver disease and cirrhosis \u2013 current status and future directions","volume":"61","author":"Iwakiri","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0370","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.3748\/wjg.v20.i10.2555","article-title":"Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis","volume":"20","author":"Bolognesi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0375","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/gut.2010.235473","article-title":"Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis","volume":"60","author":"M\u00f8ller","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0380","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.20993","article-title":"The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule","volume":"43","author":"Iwakiri","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0385","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0016-5085(95)90449-2","article-title":"Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats","volume":"108","author":"Lopez-Talavera","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0390","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"Bernardi","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0395","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1152\/ajpheart.01227.2006","article-title":"Reduced baroreflex sensitivity in alcoholic cirrhosis: relations to hemodynamics and humoral systems","volume":"292","author":"M\u00f8ller","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0400","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2007.10.055","article-title":"Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis","volume":"134","author":"Stadlbauer","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0405","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/00365520500292962","article-title":"Determinants of the renin\u2013angiotensin\u2013aldosterone system in cirrhosis with special emphasis on the central blood volume","volume":"41","author":"M\u00f8ller","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0410","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/j.ajkd.2015.09.013","article-title":"Pathogenesis of hepatorenal syndrome: implications for therapy","volume":"67","author":"Durand","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0415","doi-asserted-by":"crossref","unstructured":"European Association of the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018;69:406\u201360.","DOI":"10.1016\/j.jhep.2018.08.009"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0420","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-8278(03)00188-0","article-title":"Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety","volume":"39","author":"Santos","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0425","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/gut.2008.176495","article-title":"Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial","volume":"59","author":"Angeli","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0430","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0016-5085(87)91007-9","article-title":"Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study","volume":"93","author":"Gines","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0435","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0168-8278(87)80067-3","article-title":"Repeated paracentesis and i.v. albumin infusion to treat \u2018tense\u2019 ascites in cirrhotic patients. A safe alternative therapy","volume":"5","author":"Salerno","year":"1987","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0440","first-page":"164","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0445","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gines","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0450","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/hep.20559","article-title":"The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension","volume":"41","author":"Boyer","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0455","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.gastro.2003.11.016","article-title":"Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study","volume":"126","author":"Bureau","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0460","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jhep.2010.08.025","article-title":"Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS","volume":"54","author":"Bureau","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0465","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","article-title":"Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites","volume":"152","author":"Bureau","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2021.12.007","article-title":"Current treatment options of refractory ascites in liver cirrhosis \u2013 a systematic review and meta-analysis","author":"Will","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0475","first-page":"225","article-title":"Focus on midodrine: an oral peripheral-acting alpha-agonist for the treatment of orthostatic hypotension","volume":"32","author":"Mauro","year":"1997","journal-title":"Formulary"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0480","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jhep.2006.09.012","article-title":"Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites","volume":"46","author":"Kalambokis","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0485","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/hep.510280407","article-title":"Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites","volume":"28","author":"Angeli","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0490","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/1756283X16684688","article-title":"Automated low-flow ascites pump for the treatment of cirrhotic patients with refractory ascites","volume":"10","author":"Stirnimann","year":"2017","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0495","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jhep.2012.12.020","article-title":"Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study","volume":"58","author":"Bellot","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0500","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2017.06.010","article-title":"Alfapump\u00ae system vs. large volume paracentesis for refractory ascites: a multicenter randomized controlled study","volume":"67","author":"Bureau","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0505","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/1744-9987.12469","article-title":"Cell-free and concentrated ascites reinfusion therapy for decompensated liver cirrhosis","volume":"20","author":"Kozaki","year":"2016","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0510","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1148\/radiology.141.3.7029619","article-title":"The role of angiographic hemostasis in salvage of the injured spleen","volume":"141","author":"Sclafani","year":"1981","journal-title":"Radiology"},{"issue":"Suppl. 1","key":"10.1016\/j.gastrohep.2022.02.004_bib0515","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1148\/rg.25si055504","article-title":"Splenic arterial interventions: anatomy, indications, technical considerations, and potential complications","volume":"25","author":"Madoff","year":"2005","journal-title":"Radiographics"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0520","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1572-0241.2005.40559.x","article-title":"Long-term results of partial splenic artery embolization as supplemental treatment for portal-systemic encephalopathy","volume":"100","author":"Yoshida","year":"2005","journal-title":"Am JGastroenterol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0525","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2147\/RMHP.S234628","article-title":"Severe complications after splenic artery embolization for portal hypertension due to hepatic cirrhosis","volume":"13","author":"Zhang","year":"2020","journal-title":"Risk Manag Healthc Policy"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0530","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1002\/hep.32037","article-title":"Proximal splenic artery embolization to treat refractory ascites in a patient with cirrhosis","volume":"74","author":"Caporali","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0535","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5152\/dir.2021.19530","article-title":"Small-diameter TIPS combined with splenic artery embolization in the management of refractory ascites in cirrhotic patients","volume":"27","author":"Frenk","year":"2021","journal-title":"Diagn Int Radiol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0540","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/lt.22280","article-title":"Splenic artery embolization for the treatment of refractory ascites after liver transplantation","volume":"17","author":"Quintini","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0545","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/lt.24081","article-title":"Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: a 5-year experience","volume":"21","author":"Presser","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0550","doi-asserted-by":"crossref","DOI":"10.1111\/hepr.13545","article-title":"Significant improvement in portal-systemic liver failure symptoms and successful management of portal-splenic venous hemodynamics by the combinations of interventional radiology and pharmacotherapy","author":"Ishikawa","year":"2020","journal-title":"Hepatol Res"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0555","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0560","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"\u03b2 blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0565","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gutjnl-2011-301348","article-title":"The window hypothesis: haemodynamic and non-haemodynamic effects of \u03b2-blockers improve survival of patients with cirrhosis during a window in the disease","volume":"61","author":"Krag","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0570","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/gutjnl-2013-306502","article-title":"Nonselective beta-blockers are associated with improved survival in patients with ascites listed for liver transplantation","volume":"64","author":"Leithead","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0575","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJMc053519","article-title":"Beta-blockers to prevent gastroesophageal varices in cirrhosis","volume":"354","author":"Grace","year":"2006","journal-title":"N Eng J Med"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0580","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.3748\/wjg.v21.i10.3100","article-title":"Nonselective beta-blockers in cirrhotic patients with no or small varices: a meta-analysis","volume":"21","author":"Qi","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0585","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/hep.510310109","article-title":"Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites","volume":"31","author":"Perez-Paramo","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0590","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","article-title":"Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis","volume":"58","author":"Reiberger","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0595","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.28264","article-title":"Development of hyperdynamic circulation and response to \u03b2-blockers in compensated cirrhosis with portal hypertension","volume":"63","author":"Villanueva","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0600","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jhep.2020.05.011","article-title":"Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites","volume":"73","author":"T\u00e9llez","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-019-1155-1","article-title":"Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation","volume":"20","author":"Ngwa","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0610","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.cgh.2016.01.012","article-title":"Nonselective \u03b2-blockers and survival in patients with cirrhosis and ascites: a systematic review and meta-analysis","volume":"14","author":"Chirapongsathorn","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0615","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cgh.2019.05.050","article-title":"Lowering portal pressure improves outcomes of patients with or without ascites: a meta-analysis","volume":"18","author":"Turco","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0620","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jhep.2004.01.017","article-title":"Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis","volume":"40","author":"Villanueva","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0625","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease","volume":"6","author":"Bosch","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0630","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jhep.2016.11.001","article-title":"Beta adrenergic blockade and decompensated cirrhosis","volume":"66","author":"Reiberger","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0635","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.004_bib0640","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/gutjnl-2016-312129","article-title":"Beta-blockers in patients with cirrhosis and ascites: type of beta-blocker matters","volume":"65","author":"Njei","year":"2016","journal-title":"Gut"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570522000784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570522000784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:46:48Z","timestamp":1759322808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570522000784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0210570522000784"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2022.02.004","relation":{},"ISSN":["0210-5705"],"issn-type":[{"type":"print","value":"0210-5705"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of refractory ascites: Current strategies and new landscape of non-selective beta-blockers","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2022.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}